SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-000496
Filing Date
2022-03-15
Accepted
2022-03-15 08:15:57
Documents
13
Period of Report
2022-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621456_8k-plx.htm   iXBRL 8-K 27009
2 e621456_ex99-1.pdf 8-K 2389447
  Complete submission text file 0001193805-22-000496.txt   6499911

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA plxp-20220315.xsd EX-101.SCH 3036
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plxp-20220315_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION plxp-20220315_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT e621456_8k-plx_htm.xml XML 3581
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 22739189
SIC: 2834 Pharmaceutical Preparations